CHF 119.80
0.71%
Indicators
| Indicator | Value | Meaning |
|---|---|---|
| Quality rank | 89.8 | Cross-sectional percentile built by the pipeline |
| RSI 14 | 50.5 | Relative strength index over 14 days |
| SMA 20 | 119.08 | 20-day simple moving average |
| SMA 50 | 123.21 | 50-day simple moving average |
| EMA 20 | 118.70 | 20-day exponential moving average |
| ATR 14 | 2.72 | Average true range over 14 days |
| RVOL 20 | 0.86 | Volume relative to its own 20-day average |
Values are read from the stored feature table as of 2026-09-25, source yahoo. A dash means the pipeline has no value for that indicator; it is not replaced by an estimate.
Detected patterns
Gap down
2026-09-08
BEARISHStrength 96%
Gap down
2026-09-07
BEARISHStrength 38%
Volatility breakout
2026-09-01
BULLISHStrength 100%
Gap up
2026-09-01
BULLISHStrength 47%
Volatility breakout
2026-07-28
BULLISHStrength 100%
A pattern is a description of stored prices, not a prediction. Crosses need more than 200 bars, so an instrument with a short history shows fewer of them.
Related news
Novartis stock gets a higher FY2027 EPS forecast
AD HOC NEWS2026-09-28Sentiment —
OpenSecrets2026-09-26Sentiment —
Novartis (NYSE:NVS) Offers Dividend Investors a Quality Income Profile
ChartMill2026-09-26Sentiment —
A Top Novartis (NVS) Shareholder Says ‘The Party is Over’ for its Dealmaking Team
Yahoo Finance2026-09-25Sentiment —
ACCESS Newswire2026-09-25Sentiment —
Novartis defeats drug-purchaser lawsuit over delay of Entresto generics
Reuters2026-09-23Sentiment —
Novartis AG : Receives a Sell rating from Goldman Sachs
marketscreener.com2026-09-22Sentiment —
Novartis (NVS) Faces Another Pipeline Setback as ALS Drug Fails Mid-Stage Trial
Yahoo Finance2026-09-21Sentiment —